$200 million New Mexico campus expansion will create more than 250 jobs and strengthen domestic pharmaceutical production
ALBUQUERQUE, N.M. (September 3, 2026) — Curia has opened a new high-speed vial filling line at its Albuquerque campus as part of a $200 million expansion that will significantly increase the company’s sterile drug manufacturing capacity in New Mexico.
The project is expected to create more than 250 jobs in Albuquerque, with average salaries above $50,000, while strengthening the state’s growing bioscience and pharmaceutical manufacturing sector.
Gov. Michelle Lujan Grisham joined Curia CEO Phil Macnabb, Economic Development Cabinet Secretary Rob Black, Albuquerque Mayor Tim Keller and other state and local leaders for a ribbon-cutting ceremony marking the opening.
“New Mexico has built a sophisticated bioscience industry that is helping strengthen our economy and advance the science that improves lives,” said Gov. Michelle Lujan Grisham. “Curia’s continued investment in Albuquerque means more good-paying jobs for New Mexicans and greater capacity to manufacture critical medicines right here in the United States.”
New Vial Filling Line Expands Sterile Manufacturing Capabilities
Curia’s new high-speed vial filling line includes advanced sterile manufacturing technologies designed to support commercial-scale pharmaceutical production.
The new line features biosafety level 2 containment, two lyophilizers, automated inspection systems and packaging technologies.
Curia has also added a flexible filling line at its second Albuquerque facility on Balloon Park Road, supporting the production of vials, syringes and cartridges.
Together, the investments expand Curia’s ability to manufacture sterile drug products and injectable therapies while increasing flexibility across its Albuquerque operations.
“We are delighted to celebrate the opening of this important new capacity in Albuquerque,” said Curia CEO Phil Macnabb.
“Our team in New Mexico plays an essential role in the complex manufacturing process for injectable vaccines and medicines. This expansion creates new career opportunities while enabling Curia to make a greater contribution to the production of critical therapies and medicines for patients around the world.”
Expansion Could Generate More Than $1 Billion in Economic Impact
Curia has operated in Albuquerque for more than 40 years, building specialized expertise in sterile drug product manufacturing and commercial fill-finish operations.
The company’s latest expansion is expected to generate a potential economic impact of more than $1 billion over the next decade.
New Mexico supported the project with up to $5 million from the Local Economic Development Act job-creation fund, helping advance the company’s investment and employment commitments.
“Curia’s expansion is a significant investment in New Mexico’s bioscience economy and our highly skilled workforce,” said Economic Development Cabinet Secretary Rob Black.
“Projects like this demonstrate the strength of Albuquerque’s bioscience sector and the value of the state’s partnership with companies that are creating jobs and expanding their operations in New Mexico.”
Albuquerque Strengthens Position in Biopharmaceutical Manufacturing
The investment adds to Albuquerque’s growing role in bioscience, pharmaceutical production and advanced manufacturing.
Curia’s expanded capacity will support the production of injectable medicines and vaccines while reinforcing domestic pharmaceutical supply chains.
The project also builds on Curia’s work with the federal government to strengthen U.S. pharmaceutical manufacturing capacity.
The expansion received support through a cooperative agreement with the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services.
With new sterile filling capabilities, additional flexible production capacity and more than 250 jobs planned, Curia’s $200 million Albuquerque expansion represents a major investment in New Mexico’s life sciences economy and the broader U.S. pharmaceutical manufacturing sector.
